Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-663
Closed -$240K – 135
2026
Q2
$240K Buy
663
+23
+4% +$7.87K 0.21% 117
2026
Q1
$225K Sell
640
-180
-22% -$64.2K 0.22% 111
2025
Q4
$268K Buy
+820
New +$260K 0.27% 91

Other funds holding AMGN

J.M. Arbour's AMGN Position: Q3 2026 in Review

J.M. Arbour sold out of Amgen (AMGN) in Q3 2026, closing a stake of 663 shares — an estimated $240K sold.

J.M. Arbour first reported a position in AMGN in Q4 2025 and held it in 3 quarters. The position peaked at $268K in Q4 2025. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • J.M. Arbour reported no remaining Amgen position as of Q3 2026 after selling out during the quarter.
  • J.M. Arbour sold 663 Amgen shares in Q3 2026, an estimated $240K.
  • J.M. Arbour first reported a position in Amgen in Q4 2025 and held it in 3 quarters.
  • J.M. Arbour's Amgen position peaked at $268K in Q4 2025.
  • 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on J.M. Arbour's 13F filing for Q3 2026, filed 5 Nov 2026.